Proliferative Diabetic Retinopathy

2

Review clinical trials related to Proliferative Diabetic Retinopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

New Pattern of Retinal Laser Treatment for PDR

The objective of the study is to evaluate the efficacy of a new pattern of argon-laser in treating patients with proliferative diabetic retinopathy (PDR).

Participants needed: 300
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Eye & ENT Hospital of Fudan UniversityUpdated: Jan 20, 2026Locations: 1
Eligibility criteria

Having given free and informed consent to take part in the study. [+2]

Previous treatment with PRP; [+1]

Status: Recruiting

Single Session vs Multiple-Session Panretinal Photocoagulation for Treatment of Proliferative Diabetic Retinopathy

Proliferative diabetic retinopathy (PDR) is the leading cause for blindness in working-age adults. The current gold standard treatment for PDR is panretinal photocoagulation (PRP). In current clinical practice, both single-session and multiple-session PRP approaches are widely accepted and utilized. The purpose of this study is to compare the safety and effectiveness of single-session and multiple-session PRP.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Vastra Gotaland RegionUpdated: Nov 18, 2025Locations: 1
Eligibility criteria

Age > 18 years. [+4]

Intraocular surgery within the last 4 months or planned within the next 3 months... [+5]